162 Chapter 7 References 1. International Diabetes Federation. IDF diabetes atlas tenth edition 2021 [Internet]. Brussels. Belgium: International Diabetes Federation; 2021 [cited 2023 Aug 21]. Available from: https:// diabetesatlas.org/atlas/tenth-edition/ 2. Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet [Internet]. 2023 Jul 15 [cited 2023 Sep 30];402(10397):203–34. Available from: https://www.thelancet.com/journals/ lancet/article/PIIS0140-6736(23)01301-6/fulltext 3. World Health Organisation. Global Tuberculosis Report 2022 [Internet]. Geneva: WHO; 2022 [cited 2023 Sep 30]. Available from: https://www.who.int/teams/global-tuberculosis-programme/tbreports/global-tuberculosis-report-2022 4. International Diabetes Federation. Factsheets | IDF Diabetes Atlas [Internet]. Brussels, Belgium: IDF; 2022 [cited 2023 Sep 30]. Available from: https://diabetesatlas.org/regional-factsheets/ 5. Tenaye L, Mengiste B, Baraki N, Mulu E. Diabetes Mellitus among Adult Tuberculosis Patients Attending Tuberculosis Clinics in Eastern Ethiopia. BioMed Research International [Internet]. 2019 Nov 6 [cited 2023 Oct 1];2019:e7640836. Available from: https://www.hindawi.com/journals/ bmri/2019/7640836/ 6. Baghaei P, Marjani M, Javanmard P, Tabarsi P, Masjedi MR. Diabetes mellitus and tuberculosis facts and controversies. J Diabetes Metab Disord [Internet]. 2013 Dec 20 [cited 2023 Oct 1];12(1):58. Available from: https://doi.org/10.1186/2251-6581-12-58 7. Noubiap JJ, Nansseu JR, Nyaga UF, Nkeck JR, Endomba FT, Kaze AD, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosis. Lancet Glob Health. 2019 Apr;7(4):e448–60. 8. Alebel A, Wondemagegn AT, Tesema C, Kibret GD, Wagnew F, Petrucka P, et al. Prevalence of diabetes mellitus among tuberculosis patients in Sub-Saharan Africa: a systematic review and meta-analysis of observational studies. BMC Infect Dis. 2019 Mar 13;19(1):254. 9. Workneh MH, Bjune GA, Yimer SA. Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review. PLoS One. 2017;12(4):e0175925. 10. Cormier M, Schwartzman K, N’Diaye DS, Boone CE, Santos AM dos, Gaspar J, et al. Proximate determinants of tuberculosis in Indigenous peoples worldwide: a systematic review. The Lancet Global Health [Internet]. 2019 Jan 1 [cited 2023 Oct 1];7(1):e68–80. Available from: https://www. thelancet.com/journals/langlo/article/PIIS2214-109X(18)30435-2/fulltext 11. Mabula PL, Kazinyingia KI, Chavala EC, Mosha V, Msuya SE, Leyaro BJ. Prevalence and risk factors for diabetes mellitus among tuberculosis patients in Moshi Municipal Council, Kilimanjaro Tanzania. East Afr Health Res J. 2021;5(1):69–74. 12. Raghuraman S, Vasudevan KP, Govindarajan S, Chinnakali P, Panigrahi KC. Prevalence of Diabetes Mellitus among Tuberculosis Patients in Urban Puducherry. N Am J Med Sci. 2014 Jan;6(1):30–4. 13. Kajogoo VD, Amogne W, Medhin G. New onset type 2 diabetes mellitus risks with integrase strand transfer inhibitors-based regimens: A systematic review and meta-analysis. Metabolism Open. 2023;100235. 14. World Health Organisation. Policy brief: update of recommendations on first- and second-line antiretroviral regimens [Internet]. Geneva: WHO; [cited 2023 Oct 31]. Available from: https://iris. who.int/handle/10665/325892
RkJQdWJsaXNoZXIy MTk4NDMw